• Jelena Trifunović Kubat KBC "Dr Dragisa Misovic", Hospital for Gynecology and Obstetrics, Belgrade, Serbia
  • Predrag Sazdanović Clinical Center Kragujevac, Clinic for Gynecology and Obstetrics, Kragujevac Serbia. Faculty of Medicine, University of Kragujevac, Kragujevac, Serbia
  • Slađana Mihajlović Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Ivana Filipović
  • Filip Mošković Gynecology and Obstetrics Clinic "Narodni Front", Belgrade, Serbia


COVID19, pregnancy, newborn


Since the new SARS CoV2 virus was first identified in March 2020 and the pandemic has continued to spread globally, the number of infected and pregnant women requiring hospital treatment as well as treatment in intensive care units has increased. COVID19 in pregnancy has been associated with a number of negative maternal, fetal and neonatal outcomes. Physiological changes that occur in pregnancy, primarily at the level of the immune system, are key to a better understanding of COVID19 infection in pregnancy. In order to better understand the ways of virus transmission between pregnant women and their newborns, they are usually divided into intrauterine, intrapartum and postpartum infections. Although vertical transmission has  been thought to be impossible, the virus has been isolated from the fetal side of the placenta.  COVID19 in pregnancy is associated with poor maternal outcomes in terms of preclampsia, hypertension, premature termination of pregnancy, as well as an increased stillbirth rate, especially in underdeveloped and developing countries.Treatment of pregnant women does not differ significantly from therapy in non-pregnant patients, although studies have shown a significantly higher incidence of hospitalization and treatment needs in intensive care units for pregnant women compared to the general population of women with the same demographics and health status. Numerous studies have shown that pregnancy itself poses an increased risk of complications related to COVID19. Vaccines registered so far are the best specific measure for the prevention of COVID19 infection in pregnancy. By protecting pregnant women, we also protect the health of their offspring.


Joseph NT, Stanhope KK, Badell ML, Horton JP, Boulet SL, Jamieson DJ. Socio- demographic predictors of SARS-CoV-2 infec- tion in obstetric patients, Georgia, USA. Emerg Infect Dis 2020;26:2787–9.

Badr DA, Mattern J, Carlin A, et al. Are clinical outcomes worse for pregnant women at !20 weeks’ gestation infected with coro- navirus disease 2019? A multicenter case- control study with propensity score match- ing. Am J Obstet Gynecol 2020;223:764–8.

Zambrano LD, Ellington S, Strid P, et al. Up- date: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status— United States, January 22eOctober 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69: 1641–7.

Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national popula- tion based cohort study. BMJ 2020;369: m2107.

Afshar Y, Gaw SL, Flaherman VJ, et al. Clinical presentation of coronavirus disease 2019 (COVID-19) in pregnant and recently pregnant people. Obstet Gynecol 2020;136: 1117–25.

Vivanti AJ, Vauloup-Fellous C, Prevot S, et al. Transplacental transmission of SARS-CoV- 2 infection. Nat Commun 2020;11:3572.

World Health Organization. Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2 scientific brief, 8 February 2021. 2021. Available at: https://apps. Accessed February 24, 2022.

Mofenson LM, Idele P, Anthony D, et al. The evolving epidemiologic and clinical picture of SARS-CoV-2 and COVID-19 disease in children and young people. 2020. Available at: https:// Epidemiologic-Clinical-Picture-SARS-CoV2- COVID-19-Children-Young-People.pdf. Accessed February 24, 2022.

Edlow AG, Li JZ, Collier AY, et al. Assess- ment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open 2020;3:e2030455.

Groß R, Conzelmann C, Müller JA, et al. Detection of SARS-CoV-2 in human breastmilk. Lancet 2020;395:1757–8.

Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-anal- ysis. CMAJ 2021;193:E540–8.

A.M. Ciobanu, S. Colibaba, B. Cimpoca, G. Peltecu, A.M. PanaitescuThrombocytopenia in pregnancyMaedica (Bucur), 2016:11,55-60.

C.J. Lockwood, C.F. Yen, M. Basar, U.A. Kayisli, M. Martel, I. Buhimschi, C. Buhimschi, S.J. Huang, G. Krikun, F. SchatzPreeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cellsAm. J. Pathol., 172 (2008:172, 1571-1579, 10.2353/ajpath.2008.070629.

S. Figliozzi, P.G. Masci, N. Ahmadi, L. Tondi, E. Koutli, A. Aimo, K. Stamatelopoulos, M.A. Dimopoulos, A.L.P. Caforio, G. GeorgiopoulosPredictors of adverse prognosis in COVID-19: a systematic review and meta-analysisEur. J. Clin. Invest., 2020:50 Article e13362, 10.1111/eci.13362

G. Lippi, M. Plebani, B.M. Henry. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysisClin. Chim. Acta, 506 (2020), pp. 145-148, 10.1016/j.cca.2020.03.022

M. Mendoza, I. Garcia-Ruiz, N. Maiz, C. Rodo, P. Garcia-Manau, B. Serrano, R. Lopez-Martinez, J. Balcells, N. Fernandez-Hidalgo, E. Carreras, A. SuyPre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational studyBJOG An Int. J. Obstet. Gynaecol., 2020:117, 1374-1380, 10.1111/1471-0528.16339

D. Rolnik. Can COVID-19 in pregnancy cause pre-eclampsia?BJOG An Int. J. Obstet. Gynaecol., 2020:127,1381-1381.

P. Dubey, S.Y. Reddy, S. Manuel, A.K. Dwivedi. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: an updated systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol., 252 2020: 252, 490-501.

Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol 2021;137: 571–80.

Chmielewska B, Barratt I, Townsend R, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health 2021;9:e759–72.

Graham WJ, Afolabi B, Benova L, et al. Protecting hard-won gains for mothers and newborns in low-income and middle-income countries in the face of COVID-19: call for a service safety net. BMJ Glob Health 2020;5: e002754.

M. Delahoy, M. Whitaker, A. O’Halloran, e. al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 statesH.a.H. Services (2020)1347-1354.

M.C. Smithgall, X. Liu-Jarin, D. Hamele-Bena, A. Cimic, M. Mourad, L. Debelenko, X. Chen. Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization. Histopathology (2020), 10.1111/his.14215

J. Yan, J. Guo, C. Fan, J. Juan, X. Yu, J. Li, L. Feng, C. Li, H. Chen, Y. Qiao, D. Lei, C. Wang, G. Xiong, F. Xiao, W. He, Q. Pang, X. Hu, S. Wang, D. Chen, Y. Zhang, L.C. Poon, H. Yang. Coronavirus disease 2019 in pregnant women: a report based on 116 casesAm. J. Obstet. Gynecol., 223 (2020), 10.1016/j.ajog.2020.04.014

R. Gajbhiye, D. Modi, S. Mahale. Pregnancy outcomes, Newborn complications and Maternal-Fetal Transmission of SARS-CoV-2 in women with COVID-19: a systematic review of 441 casesmedRxiv (2020), p. 2020, 10.1101/2020.04.11.200623562004.2011.20062356.

D. Benhamou, H. Keita, A.S. Ducloy-Bouthors. Coagulation changes and thromboembolic risk in COVID-19 obstetric patientsAnaesth Crit Care Pain Med, 39 (2020), pp. 351-353,

S. Figliozzi, P.G. Masci, N. Ahmadi, L. Tondi, E. Koutli, A. Aimo, K. Stamatelopoulos, M.A. Dimopoulos, A.L.P. Caforio, G. Georgiopoulos. Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysisEur. J. Clin. Invest., 50 (2020), Article e13362, 10.1111/eci.13362

C. Graham, R. Chooniedass, W.P. Stefura, A.B. Becker, M.R. Sears, S.E. Turvey, P.J. Mandhane, P. Subbarao, K.T. HayGlassIn vivo immune signatures of healthy human pregnancy: inherently inflammatory or anti-inflammatory?PloS One, 12 (2017), Article e0177813, 10.1371/journal.pone.0177813

T. Herold, V. Jurinovic, C. Arnreich, B.J. Lipworth, J.C. Hellmuth, M. von Bergwelt-Baildon, M. Klein, T. Weinberger. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19J. Allergy Clin. Immunol., 146 (2020), pp. 128-

C.J. Lockwood, C.F. Yen, M. Basar, U.A. Kayisli, M. Martel, I. Buhimschi, C. Buhimschi, S.J. Huang, G. Krikun, F. SchatzPreeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cellsAm. J. Pathol., 172 (2008), pp. 1571-1579

National Institutes of Health. Coronavirus disease 2019 treatment guidelines. 2021. Accessed. Available at: https://www.covid19 Accessed February 24 2022.

SMFM. Management consideration s for pregnant patients with COVID-19. 2021. Avail- able at: Accessed February 24 2022.






Review Articles